Clinical Trials Browser

Phase 2 × Azacitidine × Dermatologic × Clear all

NCT02816021 2026-02-17

Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma

Phase 2 Active not recruiting

Melanoma